Addressing the issue, Selena said to a fan, "I shake because of my medication of lupus," and added "Also read my disclaimer. I ain't no pro," reported by E News, a US based media company.
The findings of a recent study suggest that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) -- the most common form of the chronic autoimmune disease lupus.
Patients with Antiphospholipid syndrome (APS0, an autoimmune disease that preferentially affects women, are typically given different medications to reduce their risk of blood clotting and help normalize lab values such as platelet count. Despite this, patients sometimes internally feel that
A new study suggests that restoring the balance of a protein in the blood could be a promising treatment option for systemic lupus erythematosus, also known as lupus, an untreatable autoimmune disease.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
A study supports the idea that some T cells that react to microbes also may react to normal human proteins, causing autoimmune disease. The findings promise to accelerate efforts to improve diagnostic tools and treatments for autoimmune diseases.
The human microbiome has been a hot topic over the last decade, with research pointing to disrupted bacterial communities as culprits for a host of maladies including irritable bowel syndrome, eczema, and autoimmune diseases. Most studies have focused on the microbiome within the human gut,
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon
Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterward. A better understanding of these mechanisms should